PEOPLE - Shield Diagnostics makes appointment:
This article was originally published in Clinica
UK company Shield Diagnostics has reinforced its relationship with Abbott Diagnostics by appointing Erik Hornnaess to the post of non-executive director. Mr Hornnaess has worked for Abbott Diagnostics for over 10 years and was divisional vice-president for Europe, Africa and the Middle East. Shield and Abbott signed a research agreement in February (see Clinica No 745, p11).
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.